Literature DB >> 9674719

Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group.

P Schuman1, S E Ohmit, J D Sobel, K H Mayer, V Greene, A Rompalo, R S Klein.   

Abstract

PURPOSE: Our objectives were to compare the prevalence of oropharyngeal mucosal lesions among human immunodeficiency virus (HIV) seropositive and demographically similar seronegative women, and to determine the association of oral lesions with immunosuppression, substance abuse, use of medications, and utilization of dental services. POPULATION AND METHODS: Participants in a multicenter, longitudinal cohort study of HIV infection in women were evaluated at baseline by interview, physical examination, and laboratory studies.
RESULTS: Oropharyngeal pathology was found in 40% of seropositive and 23% of seronegative women. Oral candidiasis was identified in 15% of seropositive and 3% of seronegative women. Among seropositive women, history of previous oral candidiasis, lower CD4 lymphocyte counts, and current antibiotic use were associated with oral candidiasis. Hairy leukoplakia was identified in 5% of seropositive women and was significantly associated with lower CD4 lymphocyte counts. Gingival erythema and ulcerative gingivitis were found in 23% of participants overall, but were unrelated to HIV serostatus or CD4 lymphocyte count. Substance abuse, lack of dental care, and African-American race were associated with gingival pathology.
CONCLUSION: The high prevalence of oral lesions among HIV seropositive and at-risk seronegative women underscores the need for routine oral examination and targeted treatment of this population.

Entities:  

Mesh:

Year:  1998        PMID: 9674719     DOI: 10.1016/s0002-9343(98)00110-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Authors:  C H Shiboski; H Chen; M A Ghannoum; L Komarow; S Evans; P K Mukherjee; N Isham; D Katzenstein; A Asmelash; A E Omozoarhe; S Gengiah; R Allen; S Tripathy; S Swindells
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

Review 2.  Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2011-04

3.  Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care.

Authors:  I D Coulter; K C Heslin; M Marcus; R D Hays; J Freed; C Der-Martirosia; N Guzmán-Becerra; W E Cunningham; R M Andersen; M F Shapiro
Journal:  Qual Life Res       Date:  2002-02       Impact factor: 4.147

Review 4.  Importance of Candida-bacterial polymicrobial biofilms in disease.

Authors:  Melphine M Harriott; Mairi C Noverr
Journal:  Trends Microbiol       Date:  2011-08-19       Impact factor: 17.079

5.  Epidemiological and oral manifestations of HIV-positive patients in a specialized service in Brazil.

Authors:  Erick Nelo Pedreira; Camila Lopes Cardoso; Eder do Carmo Barroso; Jorge André de Souza Santos; Felipe Paiva Fonseca; Luís Antônio de Assis Taveira
Journal:  J Appl Oral Sci       Date:  2008 Nov-Dec       Impact factor: 2.698

6.  Estimation of prevalence of periodontal disease and oral lesions and their relation to CD4 counts in HIV seropositive patients on antiretroviral therapy regimen reporting at District General Hospital, Raichur.

Authors:  Jagganatha Rao Ravi; Tuthipat Ramachandra Gururaja Rao
Journal:  J Indian Soc Periodontol       Date:  2015 Jul-Aug

7.  Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era.

Authors:  Sarat Kumar Nayak; Bijay Kumar Das; Surya Narayan Das; Namita Mohapatra; Suryakanti Nayak; Lipsa Bhuyan
Journal:  Contemp Clin Dent       Date:  2016 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.